Cite

    Brian Godman et al.. “Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs.” Expert review of pharmacoeconomics & outcomes research, vol. 11, 2011, pp. 121–129. http://access.bl.uk/ark:/81055/vdc_100120311979.0x000021